Mayne Pharma reported $332.7M in Loan Capital for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Ansell ANN:AU $ 541.8M 47.1M
Cochlear COH:AU $ 229.1M 3.3M
CSL CSL:AU $ 5.2B 136.2M
Ecofibre Ltd EOF:AU 8.36M 2.18M
Healius Ltd HLS:AU $ 1.27B 56.7M
Integral Diagnostics Ltd IDX:AU 330.58M 39.19M
Medical Developments International Ltd MVP:AU 2.94M 197K
Nanosonics Ltd NAN:AU $ 3.64M 2.62M
Next Science Ltd NXS:AU 109.8K 60.1K
Polynovo Ltd PNV:AU 7.12M 460.05K
Probiotec Ltd PBP:AU 88.82M 1.04M
Ramsay Health Care RHC:AU $ 8.43B 1.71B
ResMed RMD:AU $ 668.74M 756K
Sigma Healthcare Ltd SIG:AU 297.74M 122.14M
Sonic Healthcare SHL:AU $ 2.88B 197.28M
Telix Pharmaceuticals Ltd TLX:AU 1.91M 763K